ID   CLK2_HUMAN              Reviewed;         499 AA.
AC   P49760; B1AVS9; B5MBX6; Q96CQ0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   15-MAR-2017, entry version 173.
DE   RecName: Full=Dual specificity protein kinase CLK2;
DE            EC=2.7.12.1;
DE   AltName: Full=CDC-like kinase 2;
GN   Name=CLK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=7990150; DOI=10.1006/jmbi.1994.1763;
RA   Hanes J.J., der Kammer H., Klaudiny J.J., Scheit K.H.;
RT   "Characterization by cDNA cloning of two new human protein kinases.
RT   Evidence by sequence comparison of a new family of mammalian protein
RT   kinases.";
RL   J. Mol. Biol. 244:665-672(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=9331372;
RA   Winfield S.L., Tayebi N., Martin B.M., Ginns E.I., Sidransky E.;
RT   "Identification of three additional genes contiguous to the
RT   glucocerebrosidase locus on chromosome 1q21: implications for Gaucher
RT   disease.";
RL   Genome Res. 7:1020-1026(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lung, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=8910305; DOI=10.1074/jbc.271.44.27299;
RA   Lee K., Du C., Horn M., Rabinow L.;
RT   "Activity and autophosphorylation of LAMMER protein kinases.";
RL   J. Biol. Chem. 271:27299-27303(1996).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=9637771; DOI=10.1006/excr.1998.4083;
RA   Duncan P.I., Stojdl D.F., Marius R.M., Scheit K.H., Bell J.C.;
RT   "The Clk2 and Clk3 dual-specificity protein kinases regulate the
RT   intranuclear distribution of SR proteins and influence pre-mRNA
RT   splicing.";
RL   Exp. Cell Res. 241:300-308(1998).
RN   [7]
RP   FUNCTION.
RX   PubMed=10480872; DOI=10.1074/jbc.274.38.26697;
RA   Moeslein F.M., Myers M.P., Landreth G.E.;
RT   "The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the
RT   tyrosine phosphatase, PTP-1B.";
RL   J. Biol. Chem. 274:26697-26704(1999).
RN   [8]
RP   INTERACTION WITH UBL5.
RX   PubMed=12705895; DOI=10.1016/S0006-291X(03)00549-7;
RA   Kantham L., Kerr-Bayles L., Godde N., Quick M., Webb R.,
RA   Sunderland T., Bond J., Walder K., Augert G., Collier G.;
RT   "Beacon interacts with cdc2/cdc28-like kinases.";
RL   Biochem. Biophys. Res. Commun. 304:125-129(2003).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   FUNCTION, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=19168442; DOI=10.1161/CIRCRESAHA.108.183905;
RA   Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S.,
RA   Poller W., Schultheiss H.P., Rauch U.;
RT   "Cdc2-like kinases and DNA topoisomerase I regulate alternative
RT   splicing of tissue factor in human endothelial cells.";
RL   Circ. Res. 104:589-599(2009).
RN   [13]
RP   INTERACTION WITH RBMX.
RX   PubMed=19282290; DOI=10.1074/jbc.M901026200;
RA   Heinrich B., Zhang Z., Raitskin O., Hiller M., Benderska N.,
RA   Hartmann A.M., Bracco L., Elliott D., Ben-Ari S., Soreq H.,
RA   Sperling J., Sperling R., Stamm S.;
RT   "Heterogeneous nuclear ribonucleoprotein G regulates splice site
RT   selection by binding to CC(A/C)-rich regions in pre-mRNA.";
RL   J. Biol. Chem. 284:14303-14315(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142 AND TYR-153, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION AT SER-34 AND THR-127, AND INTERACTION WITH AKT1.
RX   PubMed=20682768; DOI=10.1074/jbc.M110.122044;
RA   Nam S.Y., Seo H.H., Park H.S., An S., Kim J.Y., Yang K.H., Kim C.S.,
RA   Jeong M., Jin Y.W.;
RT   "Phosphorylation of CLK2 at serine 34 and threonine 127 by AKT
RT   controls cell survival after ionizing radiation.";
RL   J. Biol. Chem. 285:31157-31163(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98 AND SER-142, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.89 ANGSTROMS) OF 135-496.
RG   Structural genomics consortium (SGC);
RT   "Structure of human cdc2-like kinase 2 (clk2).";
RL   Submitted (AUG-2010) to the PDB data bank.
CC   -!- FUNCTION: Dual specificity kinase acting on both serine/threonine
CC       and tyrosine-containing substrates. Phosphorylates serine- and
CC       arginine-rich (SR) proteins of the spliceosomal complex. May be a
CC       constituent of a network of regulatory mechanisms that enable SR
CC       proteins to control RNA splicing and can cause redistribution of
CC       SR proteins from speckles to a diffuse nucleoplasmic distribution.
CC       Acts as a suppressor of hepatic gluconeogenesis and glucose output
CC       by repressing PPARGC1A transcriptional activity on gluconeogenic
CC       genes via its phosphorylation. Phosphorylates PPP2R5B thereby
CC       stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1
CC       complex leading to dephosphorylation of AKT1. Phosphorylates:
CC       PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of
CC       tissue factor (F3) pre-mRNA in endothelial cells.
CC       {ECO:0000269|PubMed:10480872, ECO:0000269|PubMed:19168442,
CC       ECO:0000269|PubMed:8910305, ECO:0000269|PubMed:9637771}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole
CC       (DRB) inhibits autophosphorylation. TG003 inhibits its kinase
CC       activity and affects the regulation of alternative splicing
CC       mediated by phosphorylation of SR proteins (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with RBMX. Interacts with AKT1 and UBL5.
CC       {ECO:0000269|PubMed:12705895, ECO:0000269|PubMed:19282290,
CC       ECO:0000269|PubMed:20682768}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-750020, EBI-750020;
CC       P49759-3:CLK1; NbExp=4; IntAct=EBI-750020, EBI-11981867;
CC       P49761:CLK3; NbExp=12; IntAct=EBI-750020, EBI-745579;
CC       Q8N684:CPSF7; NbExp=3; IntAct=EBI-750020, EBI-746909;
CC       P42892:ECE1; NbExp=5; IntAct=EBI-750020, EBI-2859983;
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-750020, EBI-10172181;
CC       O95198:KLHL2; NbExp=5; IntAct=EBI-750020, EBI-746999;
CC       Q8TBB1:LNX1; NbExp=7; IntAct=EBI-750020, EBI-739832;
CC       Q9P127:LUZP4; NbExp=5; IntAct=EBI-750020, EBI-10198848;
CC       Q9BYD3:MRPL4; NbExp=3; IntAct=EBI-750020, EBI-721368;
CC       Q8NAV1:PRPF38A; NbExp=3; IntAct=EBI-750020, EBI-715374;
CC       Q14498:RBM39; NbExp=8; IntAct=EBI-750020, EBI-395290;
CC       D3DU92:RNPS1; NbExp=5; IntAct=EBI-750020, EBI-10176640;
CC       Q9BUV0:RSRP1; NbExp=5; IntAct=EBI-750020, EBI-745604;
CC       O00560:SDCBP; NbExp=3; IntAct=EBI-750020, EBI-727004;
CC       Q8TAD8:SNIP1; NbExp=6; IntAct=EBI-750020, EBI-749336;
CC       P08621:SNRNP70; NbExp=4; IntAct=EBI-750020, EBI-1049228;
CC       P78362:SRPK2; NbExp=3; IntAct=EBI-750020, EBI-593303;
CC       Q8IYB3:SRRM1; NbExp=3; IntAct=EBI-750020, EBI-1055880;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-750020, EBI-719493;
CC       Q01081-2:U2AF1; NbExp=3; IntAct=EBI-750020, EBI-10176676;
CC       Q7KZS0:UBE2I; NbExp=3; IntAct=EBI-750020, EBI-10180829;
CC       Q96MU7:YTHDC1; NbExp=5; IntAct=EBI-750020, EBI-2849854;
CC       O14978:ZNF263; NbExp=3; IntAct=EBI-750020, EBI-744493;
CC       Q53GI3:ZNF394; NbExp=3; IntAct=EBI-750020, EBI-10211248;
CC       Q8TD17:ZNF398; NbExp=5; IntAct=EBI-750020, EBI-8643207;
CC       Q8WTR7:ZNF473; NbExp=3; IntAct=EBI-750020, EBI-751409;
CC       Q15696:ZRSR2; NbExp=5; IntAct=EBI-750020, EBI-6657923;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Nucleus. Nucleus speckle.
CC       Note=Inhibition of phosphorylation at Ser-142 results in
CC       accumulation in the nuclear speckle. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Nucleus speckle. Note=Co-
CC       localizes with serine- and arginine-rich (SR) proteins in the
CC       nuclear speckles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=P49760-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P49760-2; Sequence=VSP_004856, VSP_004857;
CC         Note=Lacks the kinase domain. May be produced at very low levels
CC         due to a premature stop codon in the mRNA, leading to
CC         nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=P49760-3; Sequence=VSP_038744;
CC   -!- TISSUE SPECIFICITY: Endothelial cells.
CC       {ECO:0000269|PubMed:19168442}.
CC   -!- PTM: Autophosphorylates on all three types of residues.
CC       Phosphorylation on Ser-34 and Thr-127 by AKT1 is induced by
CC       ionizing radiation or insulin. Phosphorylation plays a critical
CC       role in cell proliferation following low dose radiation and
CC       prevents cell death following high dose radiation. Phosphorylation
CC       at Thr-344 by PKB/AKT2 induces its kinase activity which is
CC       required for its stability. The phosphorylation status at Ser-142
CC       influences its subnuclear localization; inhibition of
CC       phosphorylation at Ser-142 results in accumulation in the nuclear
CC       speckle. {ECO:0000269|PubMed:20682768,
CC       ECO:0000269|PubMed:9637771}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. Lammer subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L29218; AAA61482.1; -; mRNA.
DR   EMBL; L29216; AAA61481.1; -; mRNA.
DR   EMBL; AF023268; AAC51817.1; -; Genomic_DNA.
DR   EMBL; AL713999; CAI95098.1; -; Genomic_DNA.
DR   EMBL; BC014067; AAH14067.1; -; mRNA.
DR   EMBL; BC053603; AAH53603.1; -; mRNA.
DR   CCDS; CCDS1107.1; -. [P49760-3]
DR   CCDS; CCDS72939.1; -. [P49760-1]
DR   PIR; S53637; S53637.
DR   PIR; S53638; S53638.
DR   RefSeq; NP_001281267.1; NM_001294338.1. [P49760-1]
DR   RefSeq; NP_001281268.1; NM_001294339.1.
DR   RefSeq; NP_003984.2; NM_003993.3. [P49760-3]
DR   UniGene; Hs.73986; -.
DR   PDB; 3NR9; X-ray; 2.89 A; A/B/C=135-496.
DR   PDBsum; 3NR9; -.
DR   ProteinModelPortal; P49760; -.
DR   SMR; P49760; -.
DR   BioGrid; 107607; 97.
DR   DIP; DIP-42277N; -.
DR   IntAct; P49760; 78.
DR   MINT; MINT-1683264; -.
DR   STRING; 9606.ENSP00000354856; -.
DR   BindingDB; P49760; -.
DR   ChEMBL; CHEMBL4225; -.
DR   GuidetoPHARMACOLOGY; 1991; -.
DR   iPTMnet; P49760; -.
DR   PhosphoSitePlus; P49760; -.
DR   BioMuta; CLK2; -.
DR   DMDM; 1705919; -.
DR   MaxQB; P49760; -.
DR   PaxDb; P49760; -.
DR   PeptideAtlas; P49760; -.
DR   PRIDE; P49760; -.
DR   DNASU; 1196; -.
DR   Ensembl; ENST00000361168; ENSP00000354856; ENSG00000176444. [P49760-3]
DR   Ensembl; ENST00000368361; ENSP00000357345; ENSG00000176444. [P49760-1]
DR   Ensembl; ENST00000572269; ENSP00000459461; ENSG00000261893. [P49760-3]
DR   Ensembl; ENST00000574445; ENSP00000460443; ENSG00000261893. [P49760-1]
DR   GeneID; 1196; -.
DR   KEGG; hsa:1196; -.
DR   UCSC; uc001fjw.4; human. [P49760-1]
DR   CTD; 1196; -.
DR   DisGeNET; 1196; -.
DR   GeneCards; CLK2; -.
DR   H-InvDB; HIX0001112; -.
DR   HGNC; HGNC:2069; CLK2.
DR   HPA; HPA055366; -.
DR   HPA; HPA059507; -.
DR   MIM; 602989; gene.
DR   neXtProt; NX_P49760; -.
DR   OpenTargets; ENSG00000176444; -.
DR   PharmGKB; PA26595; -.
DR   eggNOG; KOG0671; Eukaryota.
DR   eggNOG; ENOG410XQF2; LUCA.
DR   GeneTree; ENSGT00580000081366; -.
DR   HOGENOM; HOG000203417; -.
DR   HOVERGEN; HBG107720; -.
DR   InParanoid; P49760; -.
DR   KO; K08823; -.
DR   OMA; YSIGQVR; -.
DR   OrthoDB; EOG09370FW4; -.
DR   PhylomeDB; P49760; -.
DR   TreeFam; TF101041; -.
DR   BRENDA; 2.7.12.1; 2681.
DR   SignaLink; P49760; -.
DR   SIGNOR; P49760; -.
DR   ChiTaRS; CLK2; human.
DR   EvolutionaryTrace; P49760; -.
DR   GeneWiki; CLK2; -.
DR   GenomeRNAi; 1196; -.
DR   PRO; PR:P49760; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000176444; -.
DR   CleanEx; HS_CLK2; -.
DR   ExpressionAtlas; P49760; baseline and differential.
DR   Genevisible; P49760; HS.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; IMP:UniProtKB.
DR   GO; GO:0032526; P:response to retinoic acid; IEA:Ensembl.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN         1    499       Dual specificity protein kinase CLK2.
FT                                /FTId=PRO_0000085868.
FT   DOMAIN      163    479       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     169    177       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    290    290       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     193    193       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      34     34       Phosphoserine; by PKB/AKT1.
FT                                {ECO:0000269|PubMed:20682768}.
FT   MOD_RES      98     98       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      99     99       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     127    127       Phosphothreonine; by PKB/AKT1.
FT                                {ECO:0000269|PubMed:20682768}.
FT   MOD_RES     142    142       Phosphoserine; by autocatalysis.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     153    153       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     344    344       Phosphothreonine; by PKB/AKT2.
FT                                {ECO:0000250}.
FT   VAR_SEQ     134    139       QHSSRR -> MKSLAP (in isoform 2).
FT                                {ECO:0000303|PubMed:7990150}.
FT                                /FTId=VSP_004856.
FT   VAR_SEQ     134    134       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_038744.
FT   VAR_SEQ     140    499       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7990150}.
FT                                /FTId=VSP_004857.
FT   TURN        146    149       {ECO:0000244|PDB:3NR9}.
FT   TURN        160    162       {ECO:0000244|PDB:3NR9}.
FT   STRAND      163    172       {ECO:0000244|PDB:3NR9}.
FT   STRAND      175    182       {ECO:0000244|PDB:3NR9}.
FT   TURN        183    187       {ECO:0000244|PDB:3NR9}.
FT   STRAND      189    195       {ECO:0000244|PDB:3NR9}.
FT   HELIX       199    218       {ECO:0000244|PDB:3NR9}.
FT   STRAND      229    235       {ECO:0000244|PDB:3NR9}.
FT   STRAND      238    244       {ECO:0000244|PDB:3NR9}.
FT   HELIX       250    256       {ECO:0000244|PDB:3NR9}.
FT   TURN        257    259       {ECO:0000244|PDB:3NR9}.
FT   HELIX       264    283       {ECO:0000244|PDB:3NR9}.
FT   HELIX       293    295       {ECO:0000244|PDB:3NR9}.
FT   STRAND      296    299       {ECO:0000244|PDB:3NR9}.
FT   TURN        309    311       {ECO:0000244|PDB:3NR9}.
FT   STRAND      317    319       {ECO:0000244|PDB:3NR9}.
FT   STRAND      323    325       {ECO:0000244|PDB:3NR9}.
FT   STRAND      332    336       {ECO:0000244|PDB:3NR9}.
FT   HELIX       345    347       {ECO:0000244|PDB:3NR9}.
FT   HELIX       350    353       {ECO:0000244|PDB:3NR9}.
FT   HELIX       361    376       {ECO:0000244|PDB:3NR9}.
FT   HELIX       386    397       {ECO:0000244|PDB:3NR9}.
FT   HELIX       402    407       {ECO:0000244|PDB:3NR9}.
FT   HELIX       411    413       {ECO:0000244|PDB:3NR9}.
FT   HELIX       426    434       {ECO:0000244|PDB:3NR9}.
FT   HELIX       438    441       {ECO:0000244|PDB:3NR9}.
FT   HELIX       447    459       {ECO:0000244|PDB:3NR9}.
FT   TURN        464    466       {ECO:0000244|PDB:3NR9}.
FT   HELIX       470    475       {ECO:0000244|PDB:3NR9}.
FT   HELIX       477    479       {ECO:0000244|PDB:3NR9}.
FT   HELIX       480    483       {ECO:0000244|PDB:3NR9}.
SQ   SEQUENCE   499 AA;  60090 MW;  E43BBF3BAD6EF991 CRC64;
     MPHPRRYHSS ERGSRGSYRE HYRSRKHKRR RSRSWSSSSD RTRRRRREDS YHVRSRSSYD
     DRSSDRRVYD RRYCGSYRRN DYSRDRGDAY YDTDYRHSYE YQRENSSYRS QRSSRRKHRR
     RRRRSRTFSR SSSQHSSRRA KSVEDDAEGH LIYHVGDWLQ ERYEIVSTLG EGTFGRVVQC
     VDHRRGGARV ALKIIKNVEK YKEAARLEIN VLEKINEKDP DNKNLCVQMF DWFDYHGHMC
     ISFELLGLST FDFLKDNNYL PYPIHQVRHM AFQLCQAVKF LHDNKLTHTD LKPENILFVN
     SDYELTYNLE KKRDERSVKS TAVRVVDFGS ATFDHEHHST IVSTRHYRAP EVILELGWSQ
     PCDVWSIGCI IFEYYVGFTL FQTHDNREHL AMMERILGPI PSRMIRKTRK QKYFYRGRLD
     WDENTSAGRY VRENCKPLRR YLTSEAEEHH QLFDLIESML EYEPAKRLTL GEALQHPFFA
     RLRAEPPNKL WDSSRDISR
//
